Skip to main content
Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc. — Investor Relations & Filings

Ticker · EBS ISIN · US29089Q1058 LEI · 549300YW6TUOX8BE5103 US Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2010-08-12 M&A Activity
Country US United States of America
Listing US EBS

About Emergent BioSolutions Inc.

https://emergentbiosolutions.com/

Emergent BioSolutions Inc. is a life sciences company specializing in solutions for public health threats. The company develops, manufactures, and delivers medical countermeasures for national security and public health preparedness, addressing threats such as anthrax, smallpox, botulism, and Ebola. In addition to its biodefense portfolio, Emergent provides commercial products for endemic health crises, notably the opioid epidemic. The company also offers contract development and manufacturing services through strategic partnerships, leveraging its specialized capabilities to support biopharmaceutical innovators, governments, and non-governmental organizations.

Recent filings

Filing Released Lang Actions
425 Filing
M&A Activity Classification · 100% confidence The document is a Form 8-K filed with the SEC by Emergent BioSolutions Inc. dated August 12, 2010. It announces the company's entry into a definitive agreement to acquire Trubion Pharmaceuticals, Inc. The text includes a conference call script discussing the acquisition rationale, scientific details, financial terms, and strategic vision. The content focuses on merger and acquisition activity, including deal terms and business strategy related to the acquisition. There is no indication that this is a full annual or quarterly report, audit report, earnings release, or other types of filings. The presence of a conference call transcript discussing the acquisition further supports classification related to M&A activity. Therefore, the document is best classified as M&A Activity (Code: TAR).
2010-08-12 English
4 Filing
Director's Dealing
2010-08-12 English
4 Filing
Director's Dealing
2010-08-12 English
8-K Filing
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 5, 2010, reporting the company's financial and operating results for the three and six months ended June 30, 2010. It includes a press release as an exhibit announcing these results. The text explicitly states it is a current report and the content is a financial results announcement for a quarterly period. The document length is 2667 characters, which is relatively short and primarily contains the announcement and a press release, not the full financial statements or detailed analysis. According to the definitions, an initial announcement of quarterly financial results with key highlights corresponds to an Earnings Release (ER). The document is not a full interim report (IR) because it lacks comprehensive financial statements and substantive analysis, and it is not a report publication announcement (RPA) because it contains the actual announcement text. Therefore, the best classification is Earnings Release (ER).
2010-08-06 English
10-Q Filing
Interim / Quarterly Report Q2 2010
2010-08-06 English
4 Filing
Director's Dealing
2010-07-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.